Related Experiment Videos
HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication
1Institute for Virology and Immunobiology, Julius-Maximilians University, Würzburg, Germany.
Springer Seminars in Immunopathology
|January 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adapting epicutaneous patch testing protocols to assess immediate-type skin reactions.
International journal of cosmetic science·2020
HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2016
Activating and inhibitory FcgammaRs in autoimmune disorders.
Springer seminars in immunopathology·2006
Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.
Springer seminars in immunopathology·2006
Fcepsilon- and Fcgamma-receptor signaling in diseases.
Springer seminars in immunopathology·2006
Fc gamma receptors and cancer.
Springer seminars in immunopathology·2006
FcgammaRII and multi-system autoimmune disease.
Springer seminars in immunopathology·2006
Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.
Springer seminars in immunopathology·2006
High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C.
Journal of human immunity·2026
Immunosenescence and immune-organ axis dysfunction: Potential of algal bioactives and nutritional interventions for healthy ageing.
International reviews of immunology·2026
Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Somatic Hypermutations Enhance Neutralization Breadth of IGHV3-53/3-66 Public Antibodies Against SARS-CoV-2 Variants.
Immunity, inflammation and disease·2026